Trading by management and close relations of management
Novonesis reported strong first-half 2026 results with 8% organic sales growth. The company raised its full-year 2026 outlook, increasing organic sales growth guidance to 7-8% (from 5-7%) and expecting adjusted EBITDA margin at the higher end of the 37-38% range.